When: Close above $203.87 on volume >4M shares

Then: Stage final 35% of intended weight

Wait for the upgrade trigger—a close above $203.87 on volume above 4 million shares—before entering; avoid front-running a reversal that hasn't confirmed.

• Forward EPS of $7.86 is not yet earned; consensus estimates get revised and three stacked assumptions (GTF aftermarket recovery, 150 basis points annual margin expansion, no program disruption) treat a ceiling as a floor
• The 0.87 PEG ratio collapses if RTX misses consensus by even 10%, causing PEG to jump above 1.0
• The 200 SMA at $192.07 is untested support, which the conservative analyst calls 'fragile support'—the market has not decided whether buyers will defend this level
• MACD histogram at negative 2.30 and expanding indicates bearish momentum is still accelerating
• RSI at 31.72 is approaching oversold but has not reached it; VWMA is rolling over below the 50 SMA, confirming the down move is volume-supported
• Price is below every short-term moving average—textbook confirmed downtrend
• Risk/reward math: entry at $192.07, stop at $185 (3.7% downside), realistic bounce targets $203-$211 (5-10% upside)—not 3-to-1 but closer to 1.5-to-1 to 2.5-to-1
• First resistance on bounce is the 10 EMA at $203.87, followed by 50 SMA/VWMA cluster around $207 and Bollinger middle at $211.13
• Only 30% initial tranche still deploys 1.5 to 2.1% of total portfolio capital into a confirmed downtrend with expanding bearish momentum
• China mineral risk: 12 critical mineral inputs restricted by China affecting RTX laser and missile production capacity—near-term execution risk on the $289 billion backlog
• Macro backdrop is risk-off: Brent at 101, yields rising, equities lower, Iran conflict ongoing, no Fed relief priced through year-end
• Beta of 0.287 doesn't protect against forced selling in risk-off environments; low-beta names can drop 15-20% in drawdowns

→ vs aggressive: Anchoring the investment case to a forward consensus estimate ($7.86 EPS) that has not been earned—consensus estimates get revised and three stacked assumptions (GTF aftermarket recovery, margin expansion of 150 basis points per year, no program disruption) are treated as a floor instead of a ceiling

→ vs aggressive: The 200 SMA is 'permission'—the conservative analyst directly challenges this, calling untested support 'fragile support' that the market has never validated; buying at it is 'catching a falling knife'

→ vs aggressive: Cherry-picking the Fed rate angle as a tailwind while ignoring the broader risk-off macro picture (Brent at 101, equities lower, no Fed relief); beta of 0.287 doesn't protect from forced selling in a de-risking environment

→ vs aggressive: Insufficient treatment of China mineral risk—12 critical mineral inputs restricted by China affecting RTX laser and missile production capacity is a near-term execution risk on the $289 billion backlog, not a hypothetical

Modify trader's staged entry plan: 20% of intended weight on first tranche (not 30%), explicit wait for 200 SMA test with reversal confirmation before tranche 2, position sizing at 4-5% range with tighter intraday mental stop at 190

• RTX printed 14.5% revenue growth, 28.7% EPS expansion, 150 basis points of margin lift, $9.88 billion in trailing free cash flow
• Backlog of $289 billion provides multi-year locked-in revenue visibility
• 200 SMA at 192.07 is meaningful but not permission to buy - MACD histogram at negative 2.30 still expanding, RSI at 31.72 not yet oversold, VWMA rolling over below 50 SMA
• Staged entry structure provides 2:1 to 3:1 aggregated risk/reward across three tranches vs. conservative's single-entry analysis
• Macro risk-off environment: Brent crude at 101, yields rising, equities lower, no Fed cuts priced through year-end, Iran conflict ongoing
• Beta of 0.287 helps on relative basis but does not protect from absolute drawdowns in forced-seller liquidity events
• China mineral risk: 12 critical inputs restricted, directly hitting laser and missile production - execution risk but not thesis-breaker
• First adjustment: shrink initial tranche from 30% to 20% of intended weight (roughly 1-1.4% of total portfolio)
• Second adjustment: do not deploy tranche two until 200 SMA is actually touched with reversal candle and RSI divergence
• Third adjustment: add mental stop on tranche one at 190 (below 200 SMA), position sizing at 4-5% range
• Stop at 185 serves as thesis-invalidation mark

→ vs aggressive: 200 SMA at 192.07 is not permission - MACD histogram at negative 2.30 and expanding, RSI at 31.72 not oversold, VWMA below 50 SMA - bullish momentum is not stabilizing, calling it permission is rhetorical flourish not analysis

→ vs aggressive: Beta of 0.287 does not protect from absolute drawdowns when institutions are forced sellers in risk-off environment - marginal buyer disappears first

→ vs conservative: R/R critique misapplied - trader is not doing single lump-sum entry at 192.07; staged structure across three tranches provides 2:1 to 3:1 aggregated risk/reward, not the 5-10% upside vs 3.7% downside cited

→ vs conservative: Aggressive analyst correctly identified that quality compounder's pullback carries different risk profile than generic mid-cap industrial in downtrend - both sides agree business is excellent